Millennium Management’s Cytokinetics CYTK Stock Holding History

Millennium Management’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.98M	Buy	+121,000	New	+$7.69M	﹤0.01%	2407
2025 Q1	–	Sell	-11,800	Closed	-$555K	–	5962
2024 Q4	$555K	Sell	11,800 -20,400	-63%	-$1.06M	﹤0.01%	4668
2024 Q3	$1.7M	Sell	32,200 -17,800	-36%	-$992K	﹤0.01%	3845
2024 Q2	$2.71M	Sell	50,000 -7,900	-14%	-$477K	﹤0.01%	3266
2024 Q1	$4.06M	Sell	57,900 -123,200	-68%	-$9.53M	﹤0.01%	3086
2023 Q4	$15.1M	Buy	+181,100	New	+$6.56M	0.01%	1806
2023 Q1	–	Sell	-25,000	Closed	-$1.15M	–	6451
2022 Q4	$1.15M	Buy	+25,000	New	+$1.08M	﹤0.01%	4030
2022 Q3	–	Sell	-50,000	Closed	-$1.97M	–	7133
2022 Q2	$1.97M	Buy	+50,000	New	+$2.01M	﹤0.01%	3727
2021 Q4	–	Sell	-15,200	Closed	-$543K	–	6895
2021 Q3	$543K	Buy	+15,200	New	+$447K	﹤0.01%	5265
2021 Q2	–	Sell	-10,000	Closed	-$233K	–	6612
2021 Q1	$233K	Hold	10,000	–	–	﹤0.01%	5406
2020 Q4	$208K	Buy	+10,000	New	+$183K	﹤0.01%	4779
2019 Q4	–	Sell	-250,000	Closed	-$2.85M	–	4280
2019 Q3	$2.85M	Sell	250,000 -250,000	-50%	-$3.14M	﹤0.01%	2211
2019 Q2	$5.63M	Buy	+500,000	New	+$4.82M	0.01%	1680
2015 Q4	–	Sell	-110,000	Closed	-$736K	–	3469
2015 Q3	$736K	Hold	110,000	–	–	﹤0.01%	2456
2015 Q2	$739K	Buy	+110,000	New	+$721K	﹤0.01%	2428
2014 Q2	–	Sell	-80,400	Closed	-$764K	–	3481
2014 Q1	$764K	Buy	+80,400	New	+$727K	﹤0.01%	2390

Other funds holding CYTK

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management's CYTK Position: Q1 2026 in Review

Millennium Management reduced its Cytokinetics (CYTK) stake by 57% in Q1 2026, selling an estimated $8.1M and leaving 97,959 shares worth $6.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2651.

Millennium Management first reported a position in CYTK in Q2 2013 and has held it in 48 quarters since. The position peaked at $100M in Q4 2023. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

Millennium Management held 97,959 shares of Cytokinetics worth $6.46M as of Q1 2026.
Millennium Management sold 127,497 Cytokinetics shares in Q1 2026, an estimated $8.1M.
Cytokinetics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2651 holding.
Millennium Management first reported a position in Cytokinetics in Q2 2013 and has held it in 48 quarters since.
Millennium Management's Cytokinetics position peaked at $100M in Q4 2023.
439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.